Alexion Pharmaceuticals names David Brennan as interim CEO
US drug developer Alexion Pharmaceuticals has named David Brennan as interim CEO, effective immediately.
Brennan is the former Chief Executive Officer and Executive Director of…
Read More...
Read More...
